Rapid risk assessment: Increase of Legionnaires’ disease in EU travellers returning from Dubai since October 2016
ECDC observed a significant increase in the number of cases of travel-associated Legionnaires’ disease (TALD) in EU travellers returning from Dubai during the period October 2016 to May 2017 that could not be accounted for by the increase in travel patterns from the EU.
Unusual increase in reported cases of paratyphoid A fever among travellers returning from Cambodia
This rapid risk assessment analyses the unusual increase in the number of paratyphoid A infections in EU travellers returning from Cambodia since March 2013 with a possible persistent common source.
Rapid risk assessment: Public health risks related to communicable diseases during the 2018 Hajj, Saudi Arabia, 19–24 August 2018
This document assesses the potential risk of outbreaks/transmission of communicable diseases during the 2018 Hajj.
Rapid Risk Assessment: Public health risks related to communicable diseases during the Hajj 2017, Saudi Arabia, 30 August – 4 September 2017
This document assesses the potential risk of outbreaks and transmission of communicable diseases during the Hajj taking place between 30 August and 4 September 2017.
Rapid Risk Assessment: Severe respiratory disease associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
As of 18 July 2013, 88 confirmed cases of MERS-CoV had been reported worldwide of which 45 have been fatal. To date, all cases have either occurred in the Middle East or have had direct links to a primary case infected in the Middle East. Saudi Arabia has reported 68 cases including 38 deaths. Thirteen cases have been reported from outside of the Middle East. These 13 cases resulted from seven separate chains of transmission. The primary case for each chain had been infected in the Middle East.
Increase of cases of Legionnaires’ disease in EU travellers returning from Dubai, October−December 2016
This report assesses the increase in travel-associated Legionnaires’ disease among returning EU travellers from Dubai, during October−December 2016.
Rapid risk assessment on influenza A(H7N9) China, 12 April 2013
On 31 March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) influenza virus isolated from three unlinked cases of severe respiratory disease in eastern China. This is the first time that human infection with avian influenza virus A(H7N9) has been identified.
Since then, human cases have continued to be reported from eastern China. As of 11 April, there were 38 laboratory-confirmed cases including ten deaths reported from four bordering provinces with a concentration of cases in and around Shanghai. Cases occur sporadically, without obvious epidemiological links. There is currently no confirmed human-to-human transmission.
Rapid risk assessment: Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV), 18th update, 30 June 2015
This update was prompted by the epidemic of confirmed MERS cases reported from South Korea in light of an upcoming international sports event (Universiade), as well as the identification of a travel-related MERS case in Thailand.
Rapid Risk Assessment: Severe respiratory disease associated with Middle East respiratory syndrome coronavirus - 13th update, 21 January 2015
The thirteenth updated rapid risk assessment on MERS-CoV shows a decrease in cases after the surge in October 2014, with the majority of MERS-CoV cases still reported from the Arabian Peninsula, mainly from Saudi Arabia.
Rapid risk assessment: Outbreak of Rift Valley fever in Niger, 10 October 2016
This rapid risk assessment monitors the threat posed by Rift Valley fever (RVF) which has been reported in regions of eastern and southern Africa, and in most of the sub-Saharan and West African countries.